Sulfonamides: a patent review (2008 – 2012)

Author： Carta Fabrizio   Scozzafava Andrea   Supuran Claudiu T  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.7, 2012-07, pp. : 747-758

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Secondary and tertiary sulfonamides: a patent review (2008 – 2012)

By Scozzafava Andrea   Carta Fabrizio   Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 2, 2013-02 ,pp. : 203-213

Informa Healthcare

Access to resources Recommend Favorite

Glycogen phosphorylase inhibitors: a patent review (2008 - 2012)

By Gaboriaud-Kolar Nicolas   Skaltsounis Alexios-Leandros  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 1017-1032

Informa Healthcare

Access to resources Recommend Favorite

AT1 antagonists: a patent review (2008 – 2012)

By Mavromoustakos Thomas   Agelis George   Durdagi Serdar  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1483-1494

Informa Healthcare

Access to resources Recommend Favorite

Osteoclast differentiation inhibitors: a patent review (2008 – 2012)

By Kim Seong Hwan   Moon Seong-Hee  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1591-1610

Informa Healthcare

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 – 2012)

By Dolušić Eduard   Frédérick Raphaël  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1367-1381

Informa Healthcare

Access to resources Recommend Favorite